Literature DB >> 19017490

Induction of Mac-2BP by nerve growth factor is regulated by the PI3K/Akt/NF-kappaB-dependent pathway in the HEK293 cell line.

Yuk Pheel Park1, Seung-Chul Choi, Bo-Yeon Kim, Jong-Tae Kim, Eun Young Song, Seong Ho Kang, Do-Young Yoon, Sang-Gi Paik, Kwang Dong Kim, Jong Wan Kim, Hee Gu Lee.   

Abstract

Mac-2BP is a ligand of the galectin family that has been suggested to affect tumor proliferation and metastasis formation. We assessed Mac-2BP expression at the transcriptional and translational levels to evaluate nerve growth factor (NGF)-induced Mac-2BP expression. A time kinetic analysis using reverse transcription-polymerase chain reaction showed that NGF-induced Mac-2BP transcript levels were 4-5 times higher than in controls. Mac-2BP enzyme-linked immunosorbent assay and immunofluorescence staining showed a 2-3-fold increase in intracellular and secreted Mac-2BP as a result of NGF stimulation. This increase was regulated by Akt activation and NF-kappaB binding. p65 and p50-NF-kappaB are major transcriptional factors in the Mac-2BP promoter region, and were shown to be regulated in accordance with the Akt activation states. Collectively, these results suggest that NGF induces Mac-2BP expression via the PI3K/Akt/NF-kappaB pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017490     DOI: 10.5483/bmbrep.2008.41.11.784

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  2 in total

1.  Co-culture of hepatoma cells with hepatocytic precursor (stem-like) cells inhibits tumor cell growth and invasion by downregulating Akt/NF-κB expression.

Authors:  Cheng-Jun Sui; Miao Xu; Wei-Qing Li; Jia-Mei Yang; Hong-Zhu Yan; Hui-Min Liu; Chun-Yan Xia; Hong-Yu Yu
Journal:  Oncol Lett       Date:  2016-09-13       Impact factor: 2.967

Review 2.  Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Valentina Gallo; Alyexandra Arienzo; Stefano Iacobelli; Valentina Iacobelli; Giovanni Antonini
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.